山东药玻
(600529)
| 流通市值：159.86亿 | | | 总市值：159.86亿 |
| 流通股本：6.64亿 | | | 总股本：6.64亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,087,938,009.78 | 1,314,607,277.82 | 1,343,274,311.11 | 1,466,329,926.87 |
| 应收票据及应收账款 | 1,770,483,575.04 | 1,751,975,861.53 | 1,719,526,912.21 | 1,646,346,464.57 |
| 其中：应收票据 | 782,719,435.23 | 780,677,502.44 | 691,905,868.03 | 676,231,103.74 |
| 应收账款 | 987,764,139.81 | 971,298,359.09 | 1,027,621,044.18 | 970,115,360.83 |
| 应收款项融资 | 65,422,809.9 | 49,233,635.54 | 50,229,310.75 | 54,833,544.96 |
| 预付款项 | 96,747,719.63 | 79,446,629.08 | 69,670,848.97 | 68,795,500.36 |
| 其他应收款合计 | 1,781,301.28 | 1,839,547.03 | 2,459,458.76 | 1,780,552.79 |
| 存货 | 1,206,411,867.83 | 1,080,920,893.91 | 1,033,270,321.63 | 1,054,610,571.71 |
| 其他流动资产 | 10,143,689.61 | 7,316,522.34 | 2,627,935.82 | 35,006,155.57 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 5,945,154,109.56 | 5,971,975,690 | 5,738,693,082.83 | 5,545,605,960.05 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 50,000 | 50,000 | 50,000 | 50,000 |
| 固定资产 | 3,473,295,662.24 | 3,357,723,071.1 | 2,951,381,463.47 | 2,994,659,152.84 |
| 在建工程 | 244,644,403.15 | 227,863,464.65 | 542,013,060.72 | 470,144,579.84 |
| 无形资产 | 248,926,209.12 | 250,609,157.46 | 251,997,999.94 | 253,666,243 |
| 递延所得税资产 | 38,584,162.34 | 38,806,348.14 | 38,139,728.78 | 37,802,151.87 |
| 其他非流动资产 | 28,353,249.49 | 44,145,318.92 | 65,796,073.21 | 16,793,463.24 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,033,853,686.34 | 3,919,197,360.27 | 3,849,378,326.12 | 3,773,115,590.79 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 9,979,007,795.9 | 9,891,173,050.27 | 9,588,071,408.95 | 9,318,721,550.84 |
| 流动负债: | | | | |
| 短期借款 | - | - | 1,825,579.24 | 1,825,579.24 |
| 应付票据及应付账款 | 1,472,343,971.03 | 1,408,050,294.73 | 1,376,928,985.25 | 1,393,701,560.89 |
| 其中：应付票据 | 677,397,525.41 | 649,070,712.17 | 688,069,685.8 | 628,105,970.03 |
| 应付账款 | 794,946,445.62 | 758,979,582.56 | 688,859,299.45 | 765,595,590.86 |
| 合同负债 | 58,949,539.95 | 59,790,198.18 | 70,031,435.42 | 61,788,588.12 |
| 应付职工薪酬 | 71,829,102.22 | 73,346,159.29 | 61,194,424.18 | 44,190,102.57 |
| 应交税费 | 47,837,415.99 | 47,778,921.26 | 45,863,975.01 | 34,472,084.02 |
| 其他应付款合计 | 365,772,222.15 | 426,926,826.61 | 143,337,065.05 | 120,676,617.91 |
| 应付股利 | 199,084,233.9 | 265,445,645.2 | - | - |
| 其他流动负债 | 63,976,929.83 | 62,239,266.8 | 64,331,748.67 | 69,937,705.87 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,080,709,181.17 | 2,078,131,666.87 | 1,763,513,212.82 | 1,726,592,238.62 |
| 非流动负债: | | | | |
| 递延收益 | 110,700,597.67 | 70,732,696.84 | 70,089,448.78 | 57,620,534.05 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 110,700,597.67 | 70,732,696.84 | 70,089,448.78 | 57,620,534.05 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,191,409,778.84 | 2,148,864,363.71 | 1,833,602,661.6 | 1,784,212,772.67 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 663,614,113 | 663,614,113 | 663,614,113 | 663,614,113 |
| 资本公积 | 2,687,120,521.29 | 2,687,120,521.29 | 2,687,120,521.29 | 2,687,120,521.29 |
| 专项储备 | 68,780,718.98 | 69,671,657.64 | 70,763,318.29 | 71,592,747.65 |
| 盈余公积 | 534,179,562.73 | 534,179,562.73 | 534,179,562.73 | 534,179,562.73 |
| 未分配利润 | 3,833,903,101.06 | 3,787,722,831.9 | 3,798,791,232.04 | 3,578,001,833.5 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,787,598,017.06 | 7,742,308,686.56 | 7,754,468,747.35 | 7,534,508,778.17 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,787,598,017.06 | 7,742,308,686.56 | 7,754,468,747.35 | 7,534,508,778.17 |
| 负债和股东权益合计 | 9,979,007,795.9 | 9,891,173,050.27 | 9,588,071,408.95 | 9,318,721,550.84 |
| 公告日期 | 2024-10-29 | 2024-08-27 | 2024-04-23 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |